XML 41 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2025
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended March 31, 

    

Nine Months Ended March 31, 

    

2024

    

2025

2024

    

2025

Cost of goods sold

$

214

$

258

$

701

$

728

Selling, general and administrative

6,650

7,132

20,326

21,298

Research and development

205

173

459

468

Stock-based compensation expense

$

7,069

$

7,563

$

21,486

$

22,494

Schedule of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2024

 

78,958

 

$

97.87

 

Granted

 

16,039

174.09

Exercised

 

(28,229)

92.01

Expired or forfeited

 

(507)

$

105.26

Outstanding at March 31, 2025

 

66,261

$

118.75

8.0 years

$

5,008

Exercisable at March 31, 2025

28,155

$

94.94

 

6.9 years

$

2,798

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2024

 

391,591

$

99.21

Granted

 

296,671

150.74

Vested

 

(322,909)

127.91

Forfeited

 

(9,099)

100.17

Nonvested at March 31, 2025

 

356,254

$

116.09